摘要
Abstract
OBJECTIVE:To probe into the clinical efficacy of Medilac-vita combined with yinzhihuang particles in treatment of mild and moderate neonatal jaundice.METHOD: 156 cases with mild or moderate neonatal jaundice from Jun.2015 to Jun.2016 were selected and divided into control group and observation group via random number table, with 78 cases each group.The control group was treated with Yinzhihuang particles orally, the observation group was treated with Medilac-vita combined with Yinzhihuang particles.The serum bilirubin level, onset time, jaundice regression time and clinical efficacy of two groups were recorded, and the adverse reactions during treatment were observed.RESULTS: There was no statistical significance between two groups in serum bilirubin level before treatment(P>0.05), the serum brilirubin level of observation group was significantly lower than that of control group after a 3-day-treatment, with statistically significant difference(P<0.05).The brilirubin level of observation group was significantly lower than that of control group after a 5-day-treatment, with extremely statistically significant difference(P<0.05).The onset time and jaundice regression time of observation group were significantly shorter than those of control group, with statistically significant difference(P<0.05).Both the recovery rate(78.21%, 61/78)and total effective rate(97.44%, 76/78)of observation group were significantly higher than those of control group(62.82%,49/78;87.18%,68/78), with statistically significant difference(P<0.05).No obvious adverse reactions were observed in both groups.CONCLUSIONS: The combination of Medilac-vita with Yinzhihuang particles can effectively reinforce the therapeutic effect of mild and moderate neonatal jaundice, and improve total effective rate with high security and efficacy.关键词
胆红素/新生儿黄疸/枯草杆菌二联活菌颗粒/茵栀黄颗粒Key words
Bilirubin/Neonatal jaundice/Medilac-vita/Yinzhihuang particles分类
医药卫生
